相关实验视频
Updated: Jul 16, 2025

08:39
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
1.7K
慢性脏病患者接受血液透析的症状负担和透析充分性之间的关系
Tahsin Karaaslan1, Irem Pembegul2
1Department of Nephrology, Hypertension, and Kidney Transplantation, Medeniyet University Faculty of Medicine, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkiye.
Northern clinics of Istanbul
|September 18, 2023
概括
确保足够的血液透析 (HD) 剂量可显著降低末期病 (ESKD) 患者的透析症状指数 (DSI). 优化HD充分性可以降低患者的症状负担.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 末期脏疾病 (ESKD) 需要脏替代疗法,通常是血液透析 (HD).
- 患有HD的患者经常经历显著的症状负担,影响生活质量.
- 透析的充分性是治疗有效性的衡量标准,对于患者的治疗结果至关重要.
研究的目的:
- 研究ESKD患者血液透析充足度与透析症状指数 (DSI) 之间的关系.
- 确定影响血液透析患者症状负担的因素.
主要方法:
- 一项前性研究涉及92名ESKD患者,每周三次接受血液透析.
- 收集的数据包括人口统计,血管接入类型和HD的持续时间.
- 用单个池Kt/V (spKt/V) 评估透析的充分性,并使用透析症状指数 (DSI) 测量症状负担.
主要成果:
- 较高的spKt/V比率与较低的DSI分数相关.
- 与中央静脉导管患者相比,患有动脉静脉 (AVF) 接入的患者有更好的透析充分性和较低的DSI.
- 女性性别,年龄增长和较低的经济地位独立地与更高的DSI分数相关.
结论:
- 透析充分性,特别是spKt/V比率,是透析症状指数 (DSI) 的一个重要的独立预测指标.
- 达到足够的透析剂量可以大大减少ESKD患者所经历的症状负担.
- 优化血液透析处方可以通过减轻症状严重程度来改善患者的幸福感.
相关概念视频
Hemodialysis II: Procedure and Complications
41
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
41
Hemodialysis III: Nursing Management
49
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
49
Dialysis
353
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
353
Chronic Kidney Disease III: Interprofessional Care
41
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
41
Chronic Kidney Disease II: Clinical Manifestations
29
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
29
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16

